1. Aolept
2. Neuleptil
3. Neuleptyl
4. Pericyazine
5. Propericiazine
1. Propericiazine
2. Pericyazine
3. 2622-26-6
4. Propericyazine
5. Neuleptil
6. Piperocyanomazine
7. Nemactil
8. Neulactil
9. Periciazinum
10. Aolept
11. Periciazina
12. Periciazine [inn]
13. Bayer 1409
14. 10-(3-(4-hydroxypiperidino)propyl)phenothiazine-2-carbonitrile
15. Rp 8909
16. 2-cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine
17. Skf 20,716
18. 6909 Rp
19. Ic 6002
20. Rp 8908
21. Wh 7508
22. 2-cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine
23. Propericiazine (jan)
24. F.i. 6145
25. Skf 20716
26. Propericiazine;rp 8909
27. Cyano-3 ((hydroxy-4 Piperidyl-1)-3 Propyl)-10 Phenothiazine
28. Nsc-758641
29. Rp-8909
30. Chembl251940
31. 4-piperidinol, 1-(3-(2-cyano-10-phenothiazinyl)propyl)-
32. Chebi:31981
33. 10-[3-(4-hydroxypiperidin-1-yl)propyl]phenothiazine-2-carbonitrile
34. 10-[3-(4-hydroxypiperidin-1-yl)propyl]-10h-phenothiazine-2-carbonitrile
35. Skf-20716
36. 3405m6fd73
37. Ncgc00095086-01
38. 10-(3-(4-hydroxypiperidin-1-yl)propyl)-10h-phenothiazine-2-carbonitrile
39. Propericiazine [jan]
40. Periciazinum [inn-latin]
41. Periciazina [inn-spanish]
42. 2-cyano-10-[3-(4-hydroxypiperidino)propyl]phenothiazine
43. Nelactil
44. Phenothiazine-2-carbonitrile, 10-(3-(4-hydroxypiperidino)propyl)-
45. Phenothiazine-2-carbonitrile, 10-[3-(4-hydroxypiperidino)propyl]-
46. Neuleptil (tn)
47. Einecs 220-071-3
48. Brn 0576739
49. Periciazin
50. Unii-3405m6fd73
51. 10-[3-(4-hydroxy-1-piperidinyl)propyl]-10h-phenothiazine-2-carbonitrile
52. Cyano-3 ((hydroxy-4 Piperidyl-1)-3 Propyl)-10 Phenothiazine [french]
53. 10h-phenothiazine-2-carbonitrile, 10-[3-(4-hydroxy-1-piperidinyl)propyl]-
54. Spectrum_001614
55. Starbld0016671
56. Pericyazine [mi]
57. Spectrum2_001604
58. Spectrum3_000748
59. Spectrum4_000210
60. Spectrum5_001747
61. Dsstox_cid_25910
62. Dsstox_rid_81221
63. Pericyazine [mart.]
64. Dsstox_gsid_45910
65. Bspbio_002336
66. Kbiogr_000819
67. Kbioss_002094
68. Periciazine [who-dd]
69. Divk1c_000874
70. Schembl148422
71. Spectrum1503936
72. Spbio_001607
73. Gtpl9216
74. Dtxsid5045910
75. Hms502l16
76. Kbio1_000874
77. Kbio2_002094
78. Kbio2_004662
79. Kbio2_007230
80. Kbio3_001556
81. Ninds_000874
82. Hms1922m18
83. Pharmakon1600-01503936
84. Zinc538159
85. Tox21_111417
86. Bdbm50346422
87. Ccg-39062
88. Nsc758641
89. Db01608
90. Nsc 758641
91. Rp 8909skf 20716
92. Idi1_000874
93. Ncgc00095086-02
94. Ncgc00095086-03
95. Ncgc00095086-04
96. Hy-14263
97. Cas-2622-26-6
98. Sbi-0051867.p002
99. Cs-0002963
100. Ft-0673633
101. D01485
102. F77808
103. Sr-01000872777
104. Q2622907
105. Sr-01000872777-1
106. Brd-k89669299-001-02-7
107. 10-[3-(4-hydroxy-1-piperidinyl)propyl]-10h-phenothiazine-2-carbonitrile #
Molecular Weight | 365.5 g/mol |
---|---|
Molecular Formula | C21H23N3OS |
XLogP3 | 3.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 365.15618354 g/mol |
Monoisotopic Mass | 365.15618354 g/mol |
Topological Polar Surface Area | 75.8 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 513 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For use as adjunctive medication in some psychotic patients. Propericiazine (Pericyazine)is used for the control of residual prevailing hostility, impulsiveness and aggressiveness.
Pericyazine is a phenothiazine of the piperidine group. It has been shown to reduce pathologic arousal and affective tension in some psychotic patients, while the symptoms of abnormal mental integration are relatively unaffected. It is a sedative phenothiazine with weak antipsychotic properties. It also has adrenolytic, anticholinergic, metabolic and endocrine effects, and an action on the extrapyramidal system.
N - Nervous system
N05 - Psycholeptics
N05A - Antipsychotics
N05AC - Phenothiazines with piperidine structure
N05AC01 - Periciazine
Pericyazine, like other phenothiazines, is presumed to act principally in the subcortical areas, by producing what has been described as a central adrenergic blockade of the alpha adrenergic receptors as well as antagonism of the D(1) dopamine receptor.
LOOKING FOR A SUPPLIER?